Projects funded by the NCN
Novel hybrid compounds derived from pyrrolidine-2,5-dione or imidazolidine-2,4-dione scaffold and their effect on central nervous system activity.
2017/25/B/NZ7/01048
Keywords:
pyrrolidine-2,5-dione imidazolidine-2,4-dione epilepsy neuropathic pain depression anxiety
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_16:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 12
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 575 200 PLN
Project start date (Y-m-d): 2018-01-03
Project end date (Y-m-d): 2023-01-02
Project duration:: 60 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.